Literature DB >> 9129784

P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis.

B A Clementz1, M A Geyer, D L Braff.   

Abstract

The present report investigated the relationship between P50 suppression and habituation among 20 schizophrenia and 20 normal comparison subjects. Subjects were presented with clicks delivered over headphones in a S1-S2 paradigm (clicks were separated by 500 msec; average intertrial interval was 8 sec). There were 60 total trials; the data were analyzed separately for the first and second 30 trials. The groups did not differ either on the number of usable trials or on the morphology of their P50 responses. Consistent with previous reports, schizophrenia patients demonstrated deficient P50 suppression. The overall suppression effect was not due to a group difference on S1 P50 amplitudes, but was associated with schizophrenia patients having smaller S1-S2 P50 amplitude difference scores than normal comparison subjects. Furthermore, the suppression effect appears to be more pronounced during the first than during the second block of trials. Thus, it may be important to evaluate changes in P50 responses over time among schizophrenia and normal comparison subjects.

Entities:  

Mesh:

Year:  1997        PMID: 9129784     DOI: 10.1016/S0006-3223(96)00208-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  35 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 2.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

3.  Advances in endophenotyping schizophrenia.

Authors:  David L Braff; Tiffany A Greenwood; Neal R Swerdlow; Gregory A Light; Nicholas J Schork
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

Review 4.  Genetic psychophysiology: advances, problems, and future directions.

Authors:  Andrey P Anokhin
Journal:  Int J Psychophysiol       Date:  2014-04-13       Impact factor: 2.997

5.  Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.

Authors:  Mei-Hua Hall; Grantley Taylor; Dean F Salisbury; Deborah L Levy
Journal:  Schizophr Bull       Date:  2010-04-02       Impact factor: 9.306

Review 6.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

Authors:  Boris B Quednow; Magdalena M Brzózka; Moritz J Rossner
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

Review 7.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

Review 8.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

9.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

10.  Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information?

Authors:  Colleen A Brenner; Paul D Kieffaber; Brett A Clementz; Jason K Johannesen; Anantha Shekhar; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Res       Date:  2009-07-23       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.